Roanna Ruiz
Stock Analyst at Leerink Partners
(1.19)
# 3,757
Out of 4,600 analysts
448
Total ratings
44.4%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $101.49 | +1.00% | 54 | Aug 3, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $37 | $20.08 | +84.26% | 1 | Jul 13, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | n/a | $522.33 | - | 26 | Jun 29, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | n/a | $9.07 | - | 33 | May 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $7.42 | +102.16% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $5 → $6 | $1.40 | +328.57% | 3 | May 15, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $3.78 | +138.10% | 24 | May 15, 2026 | |
| MNKD MannKind | Maintained: Buy | n/a | $4.10 | - | 1 | Feb 25, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $78.49 | - | 30 | Jan 13, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $16 | $18.62 | -14.07% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $13.30 | -32.33% | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.93 | +115.05% | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.31 | +434.35% | 6 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.15 | +10.43% | 35 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.30 | +428.30% | 27 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.45 | -59.10% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $27.22 | +61.65% | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $4.86 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $14.36 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $140.62 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $4.77 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $4.74 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $110.11 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $101.49
Upside: +1.00%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $20.08
Upside: +84.26%
United Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $522.33
Upside: -
Vir Biotechnology
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.07
Upside: -
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $7.42
Upside: +102.16%
iBio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $1.40
Upside: +328.57%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $3.78
Upside: +138.10%
MannKind
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $4.10
Upside: -
Cytokinetics
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.49
Upside: -
Trevi Therapeutics
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $18.62
Upside: -14.07%
Oct 1, 2025
Maintained: Hold
Price Target: $7 → $9
Current: $13.30
Upside: -32.33%
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.93
Upside: +115.05%
Aug 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.31
Upside: +434.35%
Aug 20, 2025
Reiterated: Buy
Price Target: $9
Current: $8.15
Upside: +10.43%
Aug 14, 2025
Reiterated: Buy
Price Target: $28
Current: $5.30
Upside: +428.30%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.45
Upside: -59.10%
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $27.22
Upside: +61.65%
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $4.86
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $14.36
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: n/a
Current: $140.62
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $4.77
Upside: n/a
May 7, 2024
Maintained: Hold
Price Target: $25
Current: $4.74
Upside: n/a
Jan 22, 2024
Maintained: Hold
Price Target: $23
Current: $110.11
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a